Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, de Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Garcia-Castaño A, De Juan A, Rivera F, Walters GB, Bjarnason H, Tryggvadottir L, Eyjolfsson GI, Bjornsdottir US, Holm H, Olafsson I, Kristjansson K, Kristvinsson H, Magnusson OT, Thorleifsson G, Gulcher JR, Kong A, Kiemeney LA, Jonsson T, Hjartarson H, Mayordomo JI, Netea-Maier RT, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Rafnar T, Stefansson K. Gudmundsson J, et al. Nat Genet. 2012 Jan 22;44(3):319-22. doi: 10.1038/ng.1046. Nat Genet. 2012. PMID: 22267200 Free PMC article.
A genome-wide association study yields five novel thyroid cancer risk loci.
Gudmundsson J, Thorleifsson G, Sigurdsson JK, Stefansdottir L, Jonasson JG, Gudjonsson SA, Gudbjartsson DF, Masson G, Johannsdottir H, Halldorsson GH, Stacey SN, Helgason H, Sulem P, Senter L, He H, Liyanarachchi S, Ringel MD, Aguillo E, Panadero A, Prats E, Garcia-Castaño A, De Juan A, Rivera F, Xu L, Kiemeney LA, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Kristvinsson H, Netea-Maier RT, Jonsson T, Mayordomo JI, Plantinga TS, Hjartarson H, Hrafnkelsson J, Sturgis EM, Thorsteinsdottir U, Rafnar T, de la Chapelle A, Stefansson K. Gudmundsson J, et al. Nat Commun. 2017 Feb 14;8:14517. doi: 10.1038/ncomms14517. Nat Commun. 2017. PMID: 28195142 Free PMC article.
Spontaneous complete regression in merkel cell carcinoma after biopsy.
Val-Bernal JF, García-Castaño A, García-Barredo R, Landeras R, De Juan A, Garijo MF. Val-Bernal JF, et al. Adv Anat Pathol. 2011 Mar;18(2):174-7; author reply 177. doi: 10.1097/PAP.0b013e31820ce11f. Adv Anat Pathol. 2011. PMID: 21326016 No abstract available.
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Sanz-Ortiz J. Rivera F, et al. Laryngoscope. 2004 Jul;114(7):1163-9. doi: 10.1097/00005537-200407000-00006. Laryngoscope. 2004. PMID: 15235341 Clinical Trial.
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J. Rivera F, et al. Clin Transl Oncol. 2007 Jan;9(1):40-7. doi: 10.1007/s12094-007-0008-5. Clin Transl Oncol. 2007. PMID: 17272229 Clinical Trial.
Diabetes mellitus following cisplatin treatment.
Nan DN, Fernández-Ayala M, Vega Villegas ME, Garcia-Castaño A, Rivera F, Lopez-Brea M, González-Macías J. Nan DN, et al. Acta Oncol. 2003;42(1):75-8. doi: 10.1080/0891060310002276. Acta Oncol. 2003. PMID: 12665335
Dendritic cell therapy in melanoma.
Alvarez-Dominguez C, Calderón-Gonzalez R, Terán-Navarro H, Salcines-Cuevas D, Garcia-Castaño A, Freire J, Gomez-Roman J, Rivera F. Alvarez-Dominguez C, et al. Ann Transl Med. 2017 Oct;5(19):386. doi: 10.21037/atm.2017.06.13. Ann Transl Med. 2017. PMID: 29114544 Free PMC article. Review.
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.
de Bruin EC, Cowell C, Warne PH, Jiang M, Saunders RE, Melnick MA, Gettinger S, Walther Z, Wurtz A, Heynen GJ, Heideman DA, Gómez-Román J, García-Castaño A, Gong Y, Ladanyi M, Varmus H, Bernards R, Smit EF, Politi K, Downward J. de Bruin EC, et al. Cancer Discov. 2014 May;4(5):606-19. doi: 10.1158/2159-8290.CD-13-0741. Epub 2014 Feb 17. Cancer Discov. 2014. PMID: 24535670 Free PMC article.
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Clin Transl Oncol. 2022 Oct;24(10):1890-1902. doi: 10.1007/s12094-022-02856-1. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739348 Free PMC article.
65 results